These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6652491)

  • 1. Arginine-vasopressin content of hippocampus and amygdala during passive avoidance behavior in rats.
    Laczi F; Gaffori O; De Kloet ER; De Wied D
    Brain Res; 1983 Dec; 280(2):309-15. PubMed ID: 6652491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of arginine-vasopressin in cerebrospinal fluid during passive avoidance behavior in rats.
    Laczi F; Gaffori O; Fekete M; de Kloet ER; de Wied D
    Life Sci; 1984 Jun; 34(24):2385-91. PubMed ID: 6727572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential responses in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior.
    Laczi F; Gaffori O; de Kloet ER; de Wied D
    Brain Res; 1983 Feb; 260(2):342-6. PubMed ID: 6831206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microinjection of arginine8-vasopressin antiserum into the dorsal hippocampus attenuates passive avoidance behavior in rats.
    Kovács GL; Buijs RM; Bohus B; van Wimersma Greidanus TB
    Physiol Behav; 1982 Jan; 28(1):45-8. PubMed ID: 7079322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.
    Kovács GL; Veldhuis HD; Versteeg DH; De Wied D
    Brain Res; 1986 Apr; 371(1):17-24. PubMed ID: 3708341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.
    Kovács GL; Bohus B; Versteeg DH; de Kloet ER; de Wied D
    Brain Res; 1979 Oct; 175(2):303-14. PubMed ID: 487159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory enhancement by intrahippocampal, intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task.
    Izquierdo I; Fin C; Schmitz PK; Da Silva RC; Jerusalinsky D; Quillfeldt JA; Ferreira MB; Medina JH; Bazan NG
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5047-51. PubMed ID: 7761446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressinergic modulation of stress responses in the central amygdala of the Roman high-avoidance and low-avoidance rat.
    Roozendaal B; Wiersma A; Driscoll P; Koolhaas JM; Bohus B
    Brain Res; 1992 Nov; 596(1-2):35-40. PubMed ID: 1468000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
    Ebenezer IS
    Neuropharmacology; 1988 Sep; 27(9):903-7. PubMed ID: 3185866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R; Diamant M; de Jong W; de Wied D
    Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohypophysial peptides and the hippocampus. I. Vasopressin immunoreactivity in the rat hippocampus.
    Tiberiis BE; Wilson N; McLennan H
    Neuropeptides; 1983 Dec; 4(1):65-72. PubMed ID: 6669224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ; Rigter H; Martinez JL; Koob GF; Le Moal M; Bloom FE
    Life Sci; 1984 Oct; 35(14):1505-12. PubMed ID: 6482669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of post-training injections of flumazenil into the amygdala, hippocampus and septum on retention of habituation and of inhibitory avoidance in rats.
    Da Cunha C; Wolfman C; Huang CH; Walz R; Koya R; Bianchin M; Medina JH; Izquierdo I
    Braz J Med Biol Res; 1991; 24(3):301-6. PubMed ID: 1668398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection.
    Wolfman C; Da Cunha C; Jerusalinsky D; Levi de Stein M; Viola H; Izquierdo I; Medina JH
    Brain Res; 1991 May; 548(1-2):74-80. PubMed ID: 1651148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D; Elands J; Kovács G
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenesis of the sexually dimorphic vasopressin cells of the bed nucleus of the stria terminalis and amygdala of rats.
    al-Shamma HA; De Vries GJ
    J Neurobiol; 1996 Jan; 29(1):91-8. PubMed ID: 8748374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinjection of anti-vasopressin serum into limbic structures of the rat brain: effects on passive avoidance responding and on local catecholamine utilization.
    Veldhuis HD; van Wimersma Greidanus TB; Versteeg DH
    Brain Res; 1987 Nov; 425(1):167-73. PubMed ID: 3427417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats.
    Tanabe S; Shishido Y; Furushiro M; Kado K; Hashimoto S; Yokokura T; Ohsawa T
    Pharmacol Biochem Behav; 1997; 57(1-2):251-6. PubMed ID: 9164579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.